Evaluation of a FlpA Glycoconjugate Vaccine with Ten N-Heptasaccharide Glycan Moieties to reduce Campylobacter jejuni Colonisation in ChickensVACCINESIF3.42024-04-090OAAI
Learning through Challenges and Enigmas: Educational Escape Room as a Predictive Experience of Motivation in University Students通过挑战和谜底学习: 教育逃生室作为大学生动机的预测经验SUSTAINABILITYIF3.32023-08-294OA
Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccinesMICROBIAL CELL FACTORIESIF4.92022-04-2115OA
PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosomeMICROBIAL CELL FACTORIESIF4.92022-01-057OA
Multivalent poultry vaccine development using Protein Glycan Coupling TechnologyMICROBIAL CELL FACTORIESIF4.92021-10-0210OA
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coliMICROBIAL CELL FACTORIESIF4.92021-05-249OAAI
Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine productionEXPERT REVIEW OF VACCINESIF4.82020-07-0529PRE
Conservation of miRNA-mediated silencing mechanisms across 600 million years of animal evolutionNUCLEIC ACIDS RESEARCHIF13.12016-09-0622OAAI
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation studyLANCETIF88.52014-08-01119OAAI
Psychiatric patients carrying the CYP2C9*2 allele require lower doses of valproic acid to achieve target plasma levelsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72013-10-011PREAI
Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreichs ataxia can be reduced upon HDAC inhibition by vitamin B3HUMAN MOLECULAR GENETICSIF3.22013-03-0769OAAI
Haloperidol versus atypical antipsychotics in the long-term treatment of schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Clinical outcome and tolerability of Duloxetine in the treatment of major depressive disorder: A 12-week study with plasma levelsEUROPEAN PSYCHIATRYIF6.72008-04-010PREAI